LINEAGE CELL THERAPEUTICS IN (LCTX): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in LCTX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
7
13F filers
Aggregate Value
$8.6M
Across holders
Last Price
$1.09
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity2 increased4 reduced5 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 3.02M | $4.0M | 45.9% | 0.0% | Reduced | $-3.3M | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 1.34M | $1.8M | 20.4% | 0.0% | Reduced | $-1.0M | Q2 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 1.28M | $1.7M | 19.5% | 0.0% | Reduced | $-425K | Q2 2026 |
| Squarepoint Ops LLC CIK 0001642575 | Hedge Fund | 445K | $583K | 6.8% | 0.0% | Added | +$395K | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 426K | $558K | 6.5% | 0.0% | Added | +$215K | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 55K | $72K | 0.8% | 0.0% | Reduced | $-44K | Q2 2026 |
| Rockefeller Capital Management L.P. CIK 0001739439 | Hedge Fund | 5K | $7K | 0.1% | 0.0% | Unchanged | +$0 | Q2 2026 |
Reduced
Hedge Fund
$4.0M· 45.9% of total· 0.0% port· 3.02M sh· $-3.3M QoQ· Q2 2026
Reduced
Hedge Fund
$1.8M· 20.4% of total· 0.0% port· 1.34M sh· $-1.0M QoQ· Q2 2026
Reduced
Hedge Fund
$1.7M· 19.5% of total· 0.0% port· 1.28M sh· $-425K QoQ· Q2 2026
Added
Hedge Fund
$583K· 6.8% of total· 0.0% port· 445K sh· +$395K QoQ· Q2 2026
Added
Hedge Fund
$558K· 6.5% of total· 0.0% port· 426K sh· +$215K QoQ· Q2 2026
Reduced
Hedge Fund
$72K· 0.8% of total· 0.0% port· 55K sh· $-44K QoQ· Q2 2026
Unchanged
Hedge Fund
$7K· 0.1% of total· 0.0% port· 5K sh· +$0 QoQ· Q2 2026
Loading recent insider activity…